BIIB · Healthcare
BIOGEN INC
Smart-money confidence
· 1 of 3 sources firing
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
37
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$30.6B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NasdaqGS
About BIOGEN INC
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE. It offers LEQEMBI for the…
Who's behind the signal
Every informed buyer we can see on BIIB, across all three feeds.
Hedge funds · 7
Glenview Capital Mgmt (Robbins)
New position
Gotham Asset Mgmt (Greenblatt)
Increased +2%
Point72 (Steve Cohen)
Decreased −27%
Millennium Management (Englander)
Unchanged
AQR Capital Management
Decreased −14%
D.E. Shaw & Co
Decreased −89%
+1 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar.
BIOGEN INC isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
1
New positions
1
Increasing
4
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.2×
% of portfolio
1.1%
Position change
NEW
1.1% of Glenview Capital Mgmt's portfolio
Trust weight: 1.1×
% of portfolio
0.2%
Position change
+2%
0.2% of Gotham Asset Mgmt's portfolio
Trust weight: 1.1×
% of portfolio
0.8%
Position change
−27%
0.8% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
—
0.1% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−14%
0.1% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−89%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−89%
0.0% of Citadel Advisors's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to BIOGEN INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell BIOGEN INC or any security.
Get the Weekly Update
Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime